Industry Analysis & Industry Trends
Revenue for the Flea and Tick Product Manufacturing OTC industry has remained relatively stable over the past five years, growing slightly. In general, consumer demand for pet products, particularly pharmaceutical treatments, carries a somewhat inelastic quality. Many consumers treat their pets as members of their family, sparing no cost to ensure the health and wellbeing of the animal. Over the next five years, the industry will continue to benefit from steady demand from pet owners while heavier expenditure in research and development (R&D) will drive firms to produce high-margin products that will drive profitability.... purchase to read more
Industry Report - Industry SWOT Analysis Chapter
IBISWorld analysis reveals that the Flea and Tick Product Manufacturing OTC industry is in the mature stage of its life cycle. Industry value added (IVA), a measure of the industry's contribution to the overall economy, is expected to grow at an annualized rate of 0.9% over the 10 years to 2017. Comparatively, US GDP growth is expected to reach 1.8% over the same period. In general, industry firms have benefited from relatively stable consumer demand for their products because many pet owners prefer to curtail discretionary spending of their own before foregoing spending to ensure the health and wellbeing of their animals. As a result, this industry was able to evade severe losses during the recession as other manufacturing industries crumbled... purchase to read more